The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Open accessAbstract
In 2009, the American Cancer Society (ACS) Prostate Cancer Advisory Committee began the process of a complete update of recommendations for early prostate cancer detection. A series of systematic evidence reviews was conducted focusing on evidence related to the early detection of prostate cancer, test performance, harms of therapy for localized prostate cancer, and shared and informed decision making in prostate cancer screening. The results of the systematic reviews were evaluated by the ACS Prostate Cancer Advisory Committee, and deliberations about the evidence occurred at committee meetings and during conference calls. On the basis of the evidence and a consensus process, the Prostate Cancer Advisory Committee developed the guideline, and a writing committee drafted a guideline document that was circulated to the entire committee for review and revision. The document was then circulated to peer reviewers for feedback, and finally to the ACS Mission Outcomes Committee and the ACS Board of Directors for approval. The ACS recommends that asymptomatic men who have at least a 10-year life expectancy have an opportunity to make an informed decision with their health care provider about screening for prostate cancer after they receive information about the uncertainties, risks, and potential benefits associated with prostate cancer screening. Prostate cancer screening should not occur without an informed decision-making process. Men at average risk should receive this information beginning at age 50 years. Men in higher risk groups should receive this information before age 50 years. Men should either receive this information directly from their health care providers or be referred to reliable and culturally appropriate sources. Patient decision aids are helpful in preparing men to make a decision whether to be tested.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171501 · Cited by 2,451
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241702 · Cited by 2,361
Elwyn, G. (2006) · BMJ · doi:10.1136/bmj.38926.629329.ae · Cited by 1,824
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Self-citationLongitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003
Etzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Self-citationAssessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Self-citationSmith, R. A., von Eschenbach, A. C., Wender, R., Levin, B., Byers, T., Rothenberger, D., Brooks, D., Creasman, W., Cohen, C., Runowicz, C., et al. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.38 · Cited by 821
Self-citationComparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy
Hu, J. C. (2009) · JAMA · doi:10.1001/jama.2009.1451 · Cited by 816
Draisma, G., Etzioni, R., Tsodikov, A., Mariotto, A., Wever, E., Gulati, R., Feuer, E., & de Koning, H. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp001 · Cited by 796
Self-citationCooner, W. H., Mosley, B. R., Rutherford, C. L., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C., & Kidd, D. D. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)40211-4 · Cited by 767
Zelefsky, M. J., Levin, E. J., Hunt, M., Yamada, Y., Shippy, A. M., Jackson, A., & Amols, H. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.044 · Cited by 735
Quality of Life after Radical Prostatectomy or Watchful Waiting
Steineck, G., Helgesen, F., Adolfsson, J., Dickman, P. W., Johansson, J.-E., Norlén, B. J., & Holmberg, L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021483 · Cited by 722
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Potosky, A. L., Davis, W. W., Hoffman, R. M., Stanford, J. L., Stephenson, R. A., Penson, D. F., & Harlan, L. C. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh259 · Cited by 680
Walter, L. C. (2001) · JAMA · doi:10.1001/jama.285.23.2987 · Cited by 674
Hankey, B. F., Feuer, E. J., Clegg, L. X., Hayes, R. B., Legler, J. M., Prorok, P. C., Ries, L. A., Merrill, R. M., & Kaplan, R. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1017 · Cited by 652
Carter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J., & Metter, E. J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj410 · Cited by 556
Prostate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
Rethinking Screening for Breast Cancer and Prostate Cancer
Esserman, L. (2009) · JAMA · doi:10.1001/jama.2009.1498 · Cited by 516
Pelvic Lymph Node Dissection in Prostate Cancer
Briganti, A., Blute, M. L., Eastham, J. H., Graefen, M., Heidenreich, A., Karnes, J. R., Montorsi, F., & Studer, U. E. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.012 · Cited by 501
Shared decision making about screening and chemoprevention
Sheridan, S. L., Harris, R. P., & Woolf, S. H. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.09.011 · Cited by 441
Outcomes of Localized Prostate Cancer Following Conservative Management
Lu-Yao, G. L. (2009) · JAMA · doi:10.1001/jama.2009.1348 · Cited by 430
Sirovich, B. E., Schwartz, L. M., & Woloshin, S. (2003) · JAMA · doi:10.1001/jama.289.11.1414 · Cited by 369
Promoting informed decisions about cancer screening in communities and healthcare systems
Briss, P., Rimer, B., Reilley, B., Coates, R. C., Lee, N. C., Mullen, P., Corso, P., Hutchinson, A. B., Hiatt, R., Kerner, J., et al. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2003.09.012 · Cited by 338
Shared Decision Making in Health Care: Achieving evidence-based patient choice
(2016) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780198723448.001.0001 · Cited by 332
Basic Issues in Population Screening for Cancer 23
(1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/64.5.1263 · Cited by 321
Bartsch, G., Horninger, W., Klocker, H., Reissigl, A., Oberaigner, W., Schönitzer, D., Severi, G., Robertson, C., & Boyle, P. (2001) · Urology · doi:10.1016/s0090-4295(01)01264-x · Cited by 315
Defining sexual outcomes after treatment for localized prostate carcinoma
Schover, L. R., Fouladi, R. T., Warneke, C. L., Neese, L., Klein, E. A., Zippe, C., & Kupelian, P. A. (2002) · Cancer · doi:10.1002/cncr.10848 · Cited by 305
Mettlin, C., Jones, G., Averette, H., Gusberg, S. B., & Murphy, G. P. (1993) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.43.1.42 · Cited by 301
Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study
Collin, S. M., Martin, R. M., Metcalfe, C., Gunnell, D., Albertsen, P. C., Neal, D., Hamdy, F., Stephens, P., Lane, J. A., Moore, R., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70104-9 · Cited by 272
Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer
Galvão, D. A., Spry, N. A., Taaffe, D. R., Newton, R. U., Stanley, J., Shannon, T., Rowling, C., & Prince, R. (2008) · BJU International · doi:10.1111/j.1464-410x.2008.07539.x · Cited by 270
PSA Screening Among Elderly Men With Limited Life Expectancies
Walter, L. C., Bertenthal, D., Lindquist, K., & Konety, B. R. (2006) · JAMA · doi:10.1001/jama.296.19.2336 · Cited by 262
Almeida, O. P., Waterreus, A., Spry, N., Flicker, L., & Martins, R. N. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.11.002 · Cited by 255
Vickers, A. J., Savage, C., O'Brien, M. F., & Lilja, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1685 · Cited by 254
Andriole, G. L., Levin, D. L., Crawford, E. D., Gelmann, E. P., Pinsky, P. F., Chia, D., Kramer, B. S., Reding, D., Church, T. R., Grubb, R. L., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji065 · Cited by 244
Anxiety and distress during active surveillance for early prostate cancer
van den Bergh, R. C. N., Essink‐Bot, M., Roobol, M. J., Wolters, T., Schröder, F. H., Bangma, C. H., & Steyerberg, E. W. (2009) · Cancer · doi:10.1002/cncr.24446 · Cited by 230
Labrie, F., Candas, B., Cusan, L., Gomez, J. L., Bélanger, A., Brousseau, G., Chevrette, E., & Lévesque, J. (2004) · The Prostate · doi:10.1002/pros.20017 · Cited by 227
Interexaminer variability of digital rectal examination in detecting prostate cancer
Smith, D. S., & Catalona, W. J. (1995) · Urology · doi:10.1016/s0090-4295(95)96812-1 · Cited by 221
Morgentaler, A., & Rhoden, E. L. (2006) · Urology · doi:10.1016/j.urology.2006.08.1058 · Cited by 217
Lu-Yao, G., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2002) · BMJ · doi:10.1136/bmj.325.7367.740 · Cited by 216
Interpreting Trends in Prostate Cancer Incidence and Mortality in the Five Nordic Countries
Kvale, R., Auvinen, A., Adami, H.-O., Klint, A., Hernes, E., Moller, B., Pukkala, E., Storm, H. H., Tryggvadottir, L., Tretli, S., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm249 · Cited by 195
International trends in prostate-cancer mortality in the ?PSA era?
Oliver, S. E., May, M. T., & Gunnell, D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1260 · Cited by 181
Essink-Bot, M.-L., de Koning, H. J., Nijs, H. G. T., Kirkels, W. J., van der Maas, P. J., & Schroder, F. H. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.925 · Cited by 174
Bunker, C. H., Patrick, A. L., Konety, B. R., Dhir, R., Brufsky, A., Vivas, C., Becich, M. J., Trump, D. L., & Kuller, L. H. (2002) · PubMed · Cited by 172
Recommended Prostate-Specific Antigen Testing Intervals for the Detection of Curable Prostate Cancer
Carter, H. B. (1997) · JAMA · doi:10.1001/jama.1997.03540420052029 · Cited by 167
Ross, K. S. (2000) · JAMA · doi:10.1001/jama.284.11.1399 · Cited by 161
Roemeling, S., Roobol, M. J., de Vries, S. H., Wolters, T., Gosselaar, C., van Leenders, G. J. L. H., & Schröder, F. H. (2007) · European Urology · doi:10.1016/j.eururo.2006.11.053 · Cited by 160
Trials of Decision Aids for Prostate Cancer Screening
Volk, R. J., Hawley, S. T., Kneuper, S., Holden, E. W., Stroud, L. A., Cooper, C. P., Berkowitz, J. M., Scholl, L. E., Saraykar, S., & Pavlik, V. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.07.030 · Cited by 159
Self-citationCancer Screening in Theory and in Practice
Brawley, O. W., & Kramer, B. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.107 · Cited by 157
Gore, J. L., Kwan, L. C., Lee, S. P., Reiter, R. E., & Litwin, M. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp114 · Cited by 145
Hoffman, R. M., Couper, M. P., Zikmund‐Fisher, B. J., Levin, C. A., McNaughton‐Collins, M., Helitzer, D., Hoewyk, J. V., & Barry, M. J. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.262 · Cited by 139
Volk, R. J., Jibaja‐Weiss, M. L., Hawley, S. T., Kneuper, S., Spann, S. J., Miles, B. J., & Hyman, D. J. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.07.033 · Cited by 135
Self-citationAsymptomatic Incidence and Duration of Prostate Cancer
Etzioni, R., Cha, R., Feuer, E. J., & Davidov, O. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009698 · Cited by 127
Self-citationBartsch, G. C., Horninger, W., Klocker, H., Pelzer, A. E., Bektić, J., Oberaigner, W., Schennach, H., Schäfer, G., Frauscher, F., Boniol, M., et al. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07502.x · Cited by 127
Telesca, D., Etzioni, R., & Gulati, R. (2007) · Biometrics · doi:10.1111/j.1541-0420.2007.00825.x · Cited by 123
Self-citationBasaria, S. S. (2008) · Journal of Andrology · doi:10.2164/jandrol.108.005454 · Cited by 121
Does active surveillance for men with localized prostate cancer carry psychological morbidity?
Whitaker, K. L., Parker, C. C., Dearnaley, D. P., Brewin, C. R., & Watson, M. (2007) · British Journal of Urology · doi:10.1111/j.1464-410x.2007.07009.x · Cited by 115
HEALTH RELATED QUALITY OF LIFE IN OLDER MEN WITHOUT PROSTATE CANCER
Litwin, M. S. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61624-0 · Cited by 114
Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3
Ankerst, D. P., Groskopf, J., Day, J. R., Blase, A. B., Rittenhouse, H. G., Pollock, B. H., Tangen, C. M., Parekh, D. J., Leach, R. J., & Thompson, I. M. (2008) · The Journal of Urology · doi:10.1016/j.juro.2008.06.038 · Cited by 114
Self-citationFeatures and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands)
Roobol, M. J., Kirkels, W. J., & Schröder, F. H. (2003) · British Journal of Urology · doi:10.1111/j.1464-410x.2003.04390.x · Cited by 108
Ilić, D., O’Connor, D. A., Green, S., & Wilt, T. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub2 · Cited by 108
The Effectiveness of Screening for Prostate Cancer
Concato, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.1.38 · Cited by 106
Johansson, E., Bill‐Axelson, A., Holmberg, L., Onelöv, E., Johansson, J., & Steineck, G. (2008) · European Urology · doi:10.1016/j.eururo.2008.08.054 · Cited by 104
McNaughton‐Collins, M., Fowler, F. J., Caubet, J.-F., et al. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.06.036 · Cited by 102
Parekh, D. J., Reed, A. B., Ankerst, D. P., Higgins, B., Hernández, J., Canby‐Hagino, E., Brand, T. C., Troyer, D. A., Leach, R. J., & Thompson, I. M. (2007) · The Journal of Urology · doi:10.1016/s0022-5347(18)32046-9 · Cited by 101
Self-citationDunn, A. S., Shridharani, K., Lou, W. W.-Y., Bernstein, J., & Horowitz, C. R. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(00)00288-9 · Cited by 100
The effect of study arm on prostate cancer treatment in the large screening trial ERSPC
Wolters, T., Roobol, M. J., Steyerberg, E. W., van den Bergh, R. C. N., Bangma, C. H., Hugosson, J., Ciatto, S., Kwiatkowski, M., Villers, A. A., Lujan, M., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24870 · Cited by 99
American Cancer Society guideline for the early detection of prostate cancer: update 1997
von Eschenbach, A., Ho, R. C. S., Murphy, G. P., Cunningham, M., & Lins, N. (1997) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.47.5.261 · Cited by 90
Psychological reactions in men screened for prostate cancer
Gustafsson, O., Theorell, T., Norming, U., Perski, A., Öhström, M., & Nyman, C. R. (1995) · British Journal of Urology · doi:10.1111/j.1464-410x.1995.tb07422.x · Cited by 88
Vickers, A. J., Wolters, T., Savage, C. J., Cronin, A. M., O'Brien, M. F., Pettersson, K. S. I., Roobol, M. J., Aus, G., Scardino, P. T., Hugosson, J., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.07.047 · Cited by 85
Pirl, W. F., Greer, J. A., Goode, M., & Smith, M. R. (2007) · Psycho-Oncology · doi:10.1002/pon.1206 · Cited by 80
Fowler, F. J., Barry, M. J., Walker-Corkery, B., Caubet, J.-F., Bates, D. W., Lee, J. M., Hauser, A., & McNaughton‐Collins, M. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00464.x · Cited by 79
Complications occurring from diagnostic venipuncture.
Galena, H. J. (1992) · PubMed · Cited by 75
Carlsson, S., Aus, G., Wessman, C., & Hugosson, J. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.06.002 · Cited by 73
DiBlasio, C. J., Malcolm, J. B., Derweesh, I., Womack, J. H., Kincade, M. C., Mancini, J. G. B., Ogles, M. L., Lamar, K. D., Patterson, A. L., & Wake, R. W. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07505.x · Cited by 69
Jacobsen, S. J., Bergstralh, E. J., Katusic, S. K., Guess, H. A., Darby, C. H., Silverstein, M. D., Oesterling, J. E., & Lieber, M. M. (1998) · Urology · doi:10.1016/s0090-4295(98)00171-x · Cited by 62
Etzioni, R., Cha, R., & Cowen, M. E. (1999) · The Journal of Urology · doi:10.1097/00005392-199909010-00032 · Cited by 55
Self-citationINCIDENCE AND MANAGEMENT OF GYNECOMASTIA IN MEN TREATED FOR PROSTATE CANCER
Dobs, A. S., & Darkes, M. J. M. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000176461.75794.f8 · Cited by 54
Eyre, S. J., Ankerst, D. P., Wei, J. T., Nair, P. V., Regan, M. M., Bueti, G., Tang, J. M., Rubin, M. A., Kearney, M., Thompson, I. M., et al. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.056 · Cited by 54
Self-citationBrindle, L. A., Oliver, S. E., Dedman, D., Donovan, J., Neal, D. E., Hamdy, F. C., Lane, J. A., & Peters, T. J. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06401.x · Cited by 51
Hugosson, J., Aus, G., Bergdahl, S., et al. (2003) · British Journal of Urology · doi:10.1111/j.1465-5101.2003.04396.x · Cited by 48
Taylor, K. L., Shelby, R. A., Kerner, J. F., Redd, W. H., & Lynch, J. H. (2002) · Cancer · doi:10.1002/cncr.10781 · Cited by 48
Family History and Prostate Cancer Screening With Prostate-Specific Antigen
Mäkinen, T., Tammela, T. L. J., Stenman, U., Määttänen, L., Rannikko, S., Aro, J. L. V., Juusela, H., Hakama, M., & Auvinen, A. P. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.006 · Cited by 48
Lu‐Yao, G. L., Albertsen, P. C., Stanford, J. L., Stukel, T. A., Walker-Corkery, E. S., & Barry, M. J. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0785-8 · Cited by 40
Trends and risk factors for prostate biopsy complications in the pre-PSA and PSA eras, 1980 to 1997
Roberts, R. O., Bergstralh, E. J., Besse, J. A., Lieber, M. M., & Jacobsen, S. J. (2002) · Urology · doi:10.1016/s0090-4295(01)01465-0 · Cited by 40
Beer, T. M., Tangen, C. M., Bland, L. B., Hussain, M., Goldman, B. H., DeLoughery, T. G., & Crawford, E. D. (2006) · Cancer · doi:10.1002/cncr.22029 · Cited by 40
Jim, H., Small, B. J., Patterson, S. G., Salup, R. R., & Jacobsen, P. B. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0625-3 · Cited by 36
Gosselaar, C., Roobol, M. J., Roemeling, S., de Vries, S. H., van der Cruijsen‐Koeter, I., van der Kwast, T., & Schröder, F. H. (2005) · The Prostate · doi:10.1002/pros.20359 · Cited by 35
Williams, M., Hernández, J., & Thompson, I. (2005) · Journal of Urology · doi:10.1097/01.ju.0000143193.81585.5c · Cited by 34
Self-citationProstate Cancer Risk Assessment Program: A 10-Year Update of Cancer Detection
Giri, V. N., Beebe‐Dimmer, J., Buyyounouski, M., et al. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.07.010 · Cited by 33
Studies of prostate-cancer mortality: caution advised
Etzioni, R., & Feuer, E. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70112-8 · Cited by 30
Self-citationMen's attitudes toward prostate cancer and seeking prostate-specific antigen testing.
Steginga, S. K., Occhipinti, S., McCaffrey, J., & Dunn, J. C. (2001) · PubMed · doi:10.1080/08858190109528723 · Cited by 27
Population-Based Case-Control Study of PSA and DRE Screening on Prostate Cancer Mortality
Bergstralh, E. J., Roberts, R. O., Farmer, S. A., Slezak, J. M., Lieber, M. M., & Jacobsen, S. J. (2007) · Urology · doi:10.1016/j.urology.2007.07.009 · Cited by 27
Albertsen, P. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.930 · Cited by 19
Receiver operating characteristics of the prostate specific antigen test in an unselected population
McLernon, D. J., Donnan, P. T., Gray, M., Weller, D., & Sullivan, F. (2006) · Journal of Medical Screening · doi:10.1258/096914106777589614 · Cited by 12
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4
McDermott, D. W., & Sanda, M. G. (2009) · Nature Reviews Urology · doi:10.1038/ncpuro1314 · Cited by 3
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21820 · Cited by 9,533
Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H., & Jemal, A. (2025) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21871 · Cited by 3,060
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Ultrasound Elastography: Review of Techniques and Clinical Applications
Sigrist, R. M. S., Liau, J., Kaffas, A. E., Chammas, M. C., & Willmann, J. K. (2017) · Theranostics · doi:10.7150/thno.18650 · Cited by 1,877
Metadata
- Authors
- Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., DeSantis, C., & Smith, R. A.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2010-03-01
- Volume
- 60
- Issue
- 2
- Pages
- 70-98
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2074075370
- Cited by
- 965
- References
- 104
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.